Establishment and Regulation of Chromatin Domains: Mechanistic Insights from Studies of Hemoglobin Synthesis

Progress in Nucleic Acid Research and Molecular Biology

Volumn 81, Issue , 2006, Pages 435-471

  Bresnick, Emery H ^a   Johnson, Kirby D ^a   Kim, Shin Il ^a   Im, Hogune ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBIN; HISTONE;

ANIMAL; BIOSYNTHESIS; CHEMISTRY; CHROMATIN; ERYTHROID CELL; GENETICS; HUMAN; METABOLISM; PROTEIN TERTIARY STRUCTURE; REGULATOR GENE; REVIEW;

ANIMALS; CHROMATIN; ERYTHROID CELLS; GLOBINS; HISTONES; HUMANS; LOCUS CONTROL REGION; PROTEIN STRUCTURE, TERTIARY;

EID: 33749172284     PISSN: 00796603     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6603(06)81011-1     Document Type: Review

References (211)

1. Kadonaga J.T. Regulation of RNA polymerase II transcription by sequence-specific DNA binding factors. Cell 116 (2004) 247-257
2. Archer T.K., Cordingley M.G., Wolford R.G., and Hager G.L. Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter. Mol. Cell. Biol. 11 (1991) 688-698
3. Lee D.Y., Hayes J.J., Pruss D., and Wolffe A.P. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72 (1993) 73-84
4. Tse C., Sera T., Wolffe A.P., and Hansen J.C. Disruption of higher-order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol. Cell Biol. 18 (1998) 4629-4638
5. Hager G.L., Archer T.K., Fragoso G., Bresnick E.H., Tsukagoshi Y., John S., and Smith C.L. Influence of chromatin structure on the binding of transcription factors to DNA. Cold Spring Harb. Symp. Quant. Biol. 58 (1993) 63-71
6. Evans T., and Felsenfeld G. The erythroid-specific transcription factor Eryf1: A new finger protein. Cell 58 (1989) 877-885
7. Tsai S.F., Martin D.I., Zon L.I., D'Andrea A.D., Wong G.G., and Orkin S.H. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 339 (1989) 446-451
8. Hebbes T.R., Thorne A.W., and Crane-Robinson C. A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J. 7 (1988) 1395-1402
9. Chung J.H., Whiteley M., and Felsenfeld G. A 5′ element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell 74 (1993) 505-514
10. Hardison R. Hemoglobins from bacteria to man: Evolution of different patterns of gene expression. J. Exp. Biol. 201 (1998) 1099-1117
11. Kingsley P.D., Malik J., Fantauzzo K.A., and Palis J. Yolk sacderived primitive erythroblasts enucleate during mammalian embryogenesis. Blood 104 (2004) 19-25
12. Whitelaw E., Tsai S.F., Hogben P., and Orkin S.H. Regulated expression of globin chains and the erythroid transcription factor GATA-1 during erythropoiesis in the developing mouse. Mol. Cell. Biol. 10 (1990) 6596-6606
13. Kingsley P.D., Malik J., Emerson R.L., Bushnell T.P., McGrath K.E., Bloedorn L.A., Bulger M., and Palis J. "Maturational" globin switching in primary primitive erythroid cells. Blood 107 4 (2006) 1665-1672
14. Stamatoyannopoulos G. Human hemoglobin switching. Science 252 (1991) 383
15. Tuan D., and London I.M. Mapping of DNase I-hypersensitive sites in the upstream DNA of human embryonic epsilon-globin gene in K562 leukemia cells. Proc. Natl. Acad. Sci. USA 81 (1984) 2718-2722
16. Tuan D., Solomon W., Li Q., and London I.M. The "beta-like-globin" gene domain in human erythroid cells. Proc. Natl. Acad. Sci. USA 82 (1985) 6384-6388
17. Forrester W.C., Thompson C., Elder J.T., and Groudine M. A developmentally stable chromatin structure in the human beta-globin gene cluster. Proc. Natl. Acad. Sci. USA 83 (1986) 1359-1363
18. Forrester W.C., Takegawa S., Papayannopoulou T., Stamatoyannopoulos G., and Groudine M. Evidence for a locus activation region: The formation of developmentally stable hypersensitive sites in globin-expressing hybrids. Nucleic Acids Res. 15 (1987) 10159-10177
19. Grosveld F., van Assendelft G.B., Greaves D.R., and Kollias G. Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell 51 (1987) 975-985
20. Bulger M., Schubeler D., Bender M.A., Hamilton J., Farrell C.M., Hardison R.C., and Groudine M. A complex chromatin landscape revealed by patterns of nuclease sensitivity and histone modification within the mouse beta-globin locus. Mol. Cell. Biol. 23 (2003) 5234-5244
21. Li Q., Zhang M., Duan Z., and Stamatoyannopoulos G. Structural analysis and mapping of DNase I hypersensitivity of HS5 of the beta-globin locus control region. Genomics 61 (1999) 183-193
22. Li Q., and Stamatoyannopoulos G. Hypersensitive site 5 of the human beta locus control region functions as a chromatin insulator. Blood 84 (1994) 1399-1401
23. Tanimoto K., Sugiura A., Omori A., Felsenfeld G., Engel J.D., and Fukamizu A. Human beta-globin locus control region HS5 contains CTCF- and developmental stage-dependent enhancer-blocking activity in erythroid cells. Mol. Cell. Biol. 23 (2003) 8946-8952
24. Wai A.W., Gillemans N., Raguz-Bolognesi S., Pruzina S., Zafarana G., Meijer D., Philipsen S., and Grosveld F. HS5 of the human beta-globin locus control region: A developmental stage-specific border in erythroid cells. EMBO J. 22 (2003) 4489-4500
25. Talbot D., Collis P., Antoniou M., Vidal M., Grosveld F., and Greaves D.R. A dominant control region from the human beta-globin locus conferring integration site-independent gene expression. Nature 338 (1989) 352-355
26. Ney P.A., Sorrentino B.P., Lowrey C.H., and Nienhuis A.W. Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein. Nucleic Acids Res. 18 (1990) 6011-6017
27. Ney P.A., Sorrentino B.P., McDonagh K.T., and Nienhuis A.W. Tandem AP-1-binding sites within the human beta-globin dominant control region function as an inducible enhancer in erythroid cells. Genes Dev. 4 (1990) 993-1006
28. Talbot D., and Grosveld F. The 5′HS2 of the globin locus control region enhances transcription through the interaction of a multimeric complex binding at two functionally distinct NF-E2 binding sites. EMBO J. 10 (1991) 1391-1398
29. Moon A.M., and Ley T.J. Functional properties of the beta-globin locus control region in K562 erythroleukemia cells. Blood 77 (1991) 2272-2284
30. Ellis J., Tan-Un K.C., Harper A., Michalovich D., Yannoutsos N., Philipsen S., and Grosveld F. A dominant chromatin-opening activity in 5′ hypersensitive site 3 of the human beta-globin locus control region. EMBO J. 15 (1996) 562-568
31. Bresnick E.H., and Tze L. Synergism between hypersensitive sites confers long-range gene activation by the beta-globin locus control region. Proc. Natl. Acad. Sci. USA 94 (1997) 4566-4571
32. Jackson J.D., Petrykowska H., Philipsen S., Miller W., and Hardison R. Role of DNA sequences outside the cores of DNase hypersensitive sites (HSs) in functions of the beta-globin locus control region. Domain opening and synergism between HS2 and HS3. J. Biol. Chem. 271 (1996) 11871-11878
33. Fiering S., Epner E., Robinson K., Zhuang Y., Telling A., Hu M., Martin D.I., Enver T., Ley T.J., and Groudine M. Targeted deletion of 5′HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev. 9 (1995) 2203-2213
34. Hug B.A., Wesselschmidt R.L., Fiering S., Bender M.A., Epner E., Groudine M., and Ley T.J. Analysis of mice containing a targeted deletion of beta-globin locus control region 5′ hypersensitive site 3. Mol. Cell. Biol. 16 (1996) 2906-2912
35. Bender M.A., Reik A., Close J., Telling A., Epner E., Fiering S., Hardison R., and Groudine M. Description and targeted deletion of 5′ hypersensitive site 5 and 6 of the mouse beta-globin locus control region. Blood 92 (1998) 4394-4403
36. Epner E., Reik A., Cimbora D., Telling A., Bender M.A., Fiering S., Enver T., Martin D.I., Kennedy M., Keller G., and Groudine M. The beta-globin LCR is not necessary for an open chromatin structure or developmentally regulated transcription of the native mouse beta-globin locus. Mol. Cell 2 (1998) 447-455
37. Reik A., Telling A., Zitnik G., Cimbora D., Epner E., and Groudine M. The locus control region is necessary for gene expression in the human beta-globin locus but not the maintenance of an open chromatin structure in erythroid cells. Mol. Cell. Biol. 18 (1998) 5992-6000
38. Bender M.A., Bulger M., Close J., and Groudine M. Beta-globin gene switching and DNase I sensitivity of the endogenous beta-globin locus in mice do not require the locus control region. Mol. Cell 5 (2000) 387-393
39. Bender M.A., Roach J.N., Halow J., Close J., Alami R., Bouhassira E.E., Groudine M., and Fiering S.N. Targeted deletion of 5′HS1 and 5′HS4 of the beta-globin locus control region reveals additive activity of the DNasel hypersensitive sites. Blood 98 (2001) 2022-2027
40. Forrester W.C., Epner E., Driscoll M.C., Enver T., Brice M., Papayannopoulou T., and Groudine M. A deletion of the human beta-globin locus activation region causes a major alteration in chromatin structure and replication across the entire beta-globin locus. Genes Dev. 4 (1990) 1637-1649
41. Navas P.A., Peterson K.R., Li Q., Skarpidi E., Rohde A., Shaw S.E., Clegg C.H., Asano H., and Stamatoyannopoulos G. Developmental specificity of the interaction between the locus control region and embryonic or fetal globin genes in transgenic mice with an HS3 core deletion. Mol. Cell. Biol. 18 (1998) 4188-4196
42. Navas P.A., Peterson K.R., Li Q., McArthur M., and Stamatoyannopoulos G. The 5′HS4 core element of the human beta-globin locus control region is required for high-level globin gene expression in definitive but not in primitive erythropoiesis. J. Mol. Biol. 312 (2001) 17-26
43. Peterson K.R., Clegg C.H., Navas P.A., Norton E.J., Kimbrough T.G., and Stamatoyannopoulos G. Effect of deletion of 5′HS3 or 5′HS2 of the human beta-globin locus control region on the developmental regulation of globin gene expression in beta-globin locus yeast artificial chromosome transgenic mice. Proc. Natl. Acad. Sci. USA 93 (1996) 6605-6609
44. Bungert J., Dave U., Lim K.C., Lieuw K.H., Shavit J.A., Liu Q., and Engel J.D. Synergistic regulation of human beta-globin gene switching by locus control region elements HS3 and HS4. Genes Dev. 9 (1995) 3083-3096
45. Bungert J., Tanimoto K., Patel S., Liu Q., Fear M., and Engel J.D. Hypersensitive site 2 specifies a unique function within the human beta-globin locus control region to stimulate globin gene transcription. Mol. Cell. Biol. 19 (1999) 3062-3072
46. Schleif R. DNA looping. Annu. Rev. Biochem. 61 (1992) 199-223
47. Tolhuis B., Palstra R.J., Splinter E., Grosveld F., and de Laat W. Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol. Cell 10 (2002) 1453-1475
48. Drissen R., Palstra R.J., Gillemans N., Splinter E., Grosveld F., Philipsen S., and de Laat W. The active spatial organization of the beta-globin locus requires the transcription factor EKLF. Genes Dev. 18 (2004) 2485-2490
49. Vakoc C.R., Letting D.L., Gheldof N., Sawado T., Bender M.A., Groudine M., Weiss M.J., Dekker J., and Blobel G.A. Proximity among distant regulatory elements at the beta globin locus requires GATA-1 and FOG-1. Mol. Cell 17 (2005) 453-462
50. Dekker J., Rippe K., Dekker M., and Kleckner N. Capturing chromosome conformation. Science 295 (2002) 1306-1311
51. Carter D., Chakalova L., Osborne C.S., Dai Y.F., and Fraser P. Long-range chromatin regulatory interactions in vivo. Nat. Genet. 32 (2002) 623-626
52. Ling J., Ainol L., Zhang L., Yu X., Pi W., and Tuan D. HS2 enhancer function is blocked by a transcriptional terminator inserted between the enhancer and the promoter. J. Biol. Chem. 279 (2004) 51704-51713
53. Bulger M., and Groudine M. Looping versus linking: Toward a model for long-distance gene activation. Genes Dev. 13 (1999) 2465-2477
54. Brand M., Ranish J.A., Kummer N.T., Hamilton J., Igarashi K., Francastel C., Chi T.H., Crabtree G.R., Aebersold R., and Groudine M. Dynamic changes in transcription factor complexes during erythroid differentiation revealed by quantitative proteomics. Nat. Struct. Mol. Biol. 11 (2003) 73-80
55. Hong W., Nakazawa M., Chen Y.Y., Kori R., Vakoc C.R., Rakowski C., and Blobel G.A. FOG-1 recruits the NuRD repressor complex to mediate transcriptional repression by GATA-1. EMBO J. 24 (2005) 67-78
56. Rodriquez P., Bonte E., Krijgsveld J., Kolodziej K.E., Guyot B., Heck A.J., Vyas P., de Boer E., Grosveld F., and Strouboulis J. GATA-1 forms distinct activating and repressive complexes in erythroid cells. EMBO J. 24 (2005) 2354-2366
57. Johnson K.D., Christensen H.M., Zhao B., and Bresnick E.H. Distinct mechanisms control RNA polymerase II recruitment to a tissue-specific locus control region and a downstream promoter. Mol. Cell 8 (2001) 465-471
58. Johnson K.D., Grass J.A., Im H., Park C., Choi K., and Bresnick E.H. Highly restricted localization of RNA polymerase II to the hypersensitive site cores of a tissue-specific locus control region. Mol. Cell. Biol. 23 (2003) 6468-6493
59. Lu S.J., Rowan S., Bani M.R., and Ben-David Y. Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: Evidence that NF-E2 is essential for globin expression. Proc. Natl. Acad. Sci. USA 91 (1994) 8398-8402
60. Kotkow K.J., and Orkin S.H. Dependence of globin gene expression in mouse erythroleukemia cells on the NF-E2 heterodimer. Mol. Cell. Biol. 15 (1995) 4640-4647
61. Bean T.L., and Ney P.A. Multiple regions of p45 NF-E2 are required for beta-globin gene expression in erythroid cells. Nucleic Acids Res. 25 (1997) 2509-2515
62. Mosser E.A., Kasanov J.D., Forsberg E.C., Kay B.K., Ney P.A., and Bresnick E.H. Physical and functional interactions between the transactivation domain of the hematopoietic transcription factor NF-E2 and WW domains. Biochemistry 37 (1998) 13686-13695
63. Kiekhaefer C.M., Grass J.D., and Bresnick E.H. WW domain binding motif within the activation domain of the hematopoietic activator p45/NF-E2 is essential for establishment of a tissue-specific histone modification pattern. J. Biol. Chem. 279 (2004) 7456-7461
64. Vieira K.F., Levings P.P., Hill M.A., Cruselle V.J., Kang S.H., Engel J.D., and Bungert J. Recruitment of transcription complexes to the beta-globin gene locus in vivo and in vitro. J. Biol. Chem. 279 (2004) 50350-50357
65. Szutorisz H., Dillon N., and Tora L. The role of enhancers as centres for general transcription factor recruitment. Trends Biochem. Sci. 30 (2005) 593-599
66. Cheng J., Kapranov P., Drenkow J., Dike S., Brubaker S., Patel S., Long J., Stern D., Tammana H., Helt G., Sementchenko V., Piccolboni A., et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 308 (2005) 1149-1154
67. Komarnitsky P., Cho E.J., and Buratowski S. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev. 14 (2000) 2452-2460
68. Lin P.S., Marshall N.F., and Dahmus M.E. CTD phosphatase: Role in RNA polymerase II cycling and the regulation of transcript elongation. Prog. Nucleic Acid Res. Mol. Biol. 72 (2002) 333-365
69. Leach K.M., Nightingale K., Igarashi K., Levings P.P., Engel J.D., Becker P.B., and Bungert J. Reconstitution of human beta-globin locus control region hypersensitive sites in the absence of chromatin assembly. Mol. Cell. Biol. 21 (2001) 2629-2640
70. Gribnau J., Diderich K., Pruzina S., Calzolari R., and Fraser P. Intergenic transcription and developmental remodeling of chromatin subdomains in the human beta-globin locus. Mol. Cell 5 (2000) 377-386
71. Francastel C., Walters M.C., Groudine M., and Martin D.I. A functional enhancer suppresses silencing of a transgene and prevents its localization close to centrometric heterochromatin. Cell 99 (1999) 259-269
72. Kosak S.T., Skok J.A., Medina K.L., Riblet R., Le Beau M.M., Fisher A.G., and Singh H. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296 (2002) 158-162
73. Kosak S.T., and Groudine M. Form follows function: The genomic organization of cellular differentiation. Genes Dev. 18 (2004) 1371-1384
74. Misteli T. Spatial positioning: A new dimension in genome function. Cell 119 (2004) 153-156
75. Nagaich A.K., Rayasam G.V., Martinez E.D., Becker M., Qiu Y., Johnson T.A., Elbi C., Fletcher T.M., John S., and Hager G.L. Subnuclear targeting and gene targeting by steroid receptors. Ann. N. Y. Acad. Sci. 1024 (2004) 213-220
76. Zaidi S.K., Javed A., Choi J.-E., Pratap J., Javed A., Montecino M., Stein J.L., van Wijnen A.J., Lian J.B., and Stein G.S. The dynamic organization of gene-regulatory networks in nuclear microenvironments. EMBO Rep. 6 (2005) 128-133
77. Chakalova L., Debrand E., Mitchell J.A., Osborne C.S., and Fraser P. Replication and transcription: Shaping the landscape of the genome. Nat. Rev. Genet. 6 (2005) 669-677
78. Cook P.R. Predicting three-dimensional genome structure from transcriptional activity. Nat. Genet. 32 (2002) 347-352
79. Swedlow J.R., Agard D.A., and Sedat J.W. Chromosome structure inside the nucleus. Curr. Opin. Cell Biol. 5 (1993) 412-416
80. van Driel R., Fransz P.F., and Verschure P.J. The eukaryotic genome: A system regulated at different hierarchical levels. J. Cell Sci. 116 (2003) 4067-4075
81. Spector D.L. The dynamics of chromosome organization and gene regulation. Annu. Rev. Biochem. 72 (2003) 573-608
82. Ragoczy T., Telling A., Sawado T., Groudine M., and Kosak S.T. A genetic analysis of chromosome territory looping: Diverse roles for distal regulatory elements. Chromosome Res. 11 (2003) 513-525
83. Shelton D.A., Stegman L., Hardison R., Miller W., Bock J.H., Slightom J.L., Goodman M., and Gumucio D.L. Phylogenetic footprinting of hypersensitive site 3 of the beta-globin locus control region. Blood 89 (1997) 3457-3469
84. Hardison R., Slightom J.L., Gumucio D.L., Goodman M., Stojanovic N., and Miller W. Locus control regions of mammalian beta-globin gene clusters: Combining phylogenetic analyses and experimental results to gain functional insights. Gene 205 (1997) 73-94
85. Li Q., Peterson K.R., Fang X.R., and Stamatoyannopoulos G. Locus control regions. Blood 100 (2002) 3077-3086
86. Cantor A.B., and Orkin S.H. Transcriptional regulation of erythropoiesis: An affair involving multiple partners. Oncogene 21 (2002) 3368-3376
87. Johnson K.D., and Bresnick E.H. Dissecting long-range transcriptional mechanisms by chromatin immunoprecipitation. METHODS 26 (2002) 27-36
88. Tuan D.Y., Solomon W.B., London I.M., and Lee D.P. An erythroid-specific, developmental-stage-independent enhancer far upstream of the human "beta-like globin" genes. Proc. Natl. Acad. Sci. USA 86 (1989) 2554-2558
89. Moon A.M., and Ley T.J. Conservation of the primary structure, organization, and function of the human and mouse beta-globin locus-activating regions. Proc. Natl. Acad. Sci. USA 87 (1990) 7693-7697
90. Fraser P., Hurst J., Collis P., and Grosveld F. DNasel hypersensitive sites 1, 2 and 3 of the human beta-globin dominant control region direct position-independent expression. Nucleic Acids Res. 18 (1990) 3503-3508
91. Eferl R., and Wagner E.F. AP1: A double-edged sword in tumorigenesis. Nat. Rev. Cancer 3 (2003) 859-868
92. Andrews N.C., Erdjument-Bromage H., Davidson M.B., Tempst P., and Orkin S.H. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 362 (1993) 722-728
93. Ney P.A., Andrews N.C., Jane S.M., Safer B., Purucker M.E., Weremowicz S., Morton C.C., Goff S.C., Orkin S.H., and Nienhuis A.W. Purification of the human NF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner. Mol. Cell. Biol. 13 (1993) 5604-5612
94. Andrews N.C., Kotkow K.J., Ney P.A., Erdjument-Bromage H., Tempst P., and Orkin S.H. The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene. Proc. Natl. Acad. Sci. USA 90 (1993) 11488-11492
95. Motohashi H., Shavit J.A., Igarashi K., Yamamoto M., and Engel J.D. The world according to Maf. Nucleic Acids Res. 25 (1997) 2953-2959
96. Sawado T., Igarashi K., and Groudine M. Activation of beta-major globin gene transcription is associated with recruitment of NF-E2 to the beta-globin LCR and gene promoter. Proc. Natl. Acad. Sci. USA 98 (2001) 10226-10231
97. Daftari P., Gavva N.R., and Shen C.K. Distinction between AP1 and NF-E2 factor-binding at specific chromatin regions in mammalian cells. Oncogene 18 (1999) 5482-5486
98. Forsberg E.C., Downs K.M., and Bresnick E.H. Direct interaction of NF-E2 with hypersensitive site 2 of the beta-globin locus control region in living cells. Blood 96 (2000) 334-339
99. Im H., Grass J.A., Johnson K.D., Kim S.-I., Boyer M.E., Imbalzano A.N., Bieker J.J., and Bresnick E.H. Chromatin domain activation via GATA-1 utilization of a small subset of dispersed GATA motifs within a broad chromosomal region. Proc. Natl. Acad. Sci. USA 102 (2005) 17065-17070
100. Johnson K.D., Grass J.D., Boyer M.E., Kiekhaefer C.M., Blobel G.A., Weiss M.J., and Bresnick E.H. Cooperative activities of hematopoietic regulators recruit RNA polymerase II to a tissue-specific chromatin domain. Proc. Natl. Acad. Sci. USA 99 (2002) 11760-11765
101. Kiekhaefer C.M., Grass J.A., Johnson K.D., Boyer M.E., and Bresnick E.H. Hematopoietic activators establish an overlapping pattern of histone acetylation and methylation within a tissue-specific chromatin domain. Proc. Natl. Acad. Sci. USA 99 (2002) 14309-14314
102. Vettese-Dadey M., Grant P.A., Hebbes T.R., Crane-Robinson C., Allis C.D., and Workman J.L. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. EMBO J. 15 (1996) 2508-2518
103. Litt M.D., Simpson M., Gaszner M., Allis C.D., and Felsenfeld G. Correlation between histone lysine methylation and developmental changes at the chicken {beta}-globin locus. Science 9 (2001) 9
104. Litt M.D., Simpson M., Recillas-Targa F., Prioleau M.N., and Felsenfeld G. Transitions in histone acetylation reveal boundaries of three separately regulated neighboring loci. EMBO J. 20 (2001) 2224-2235
105. Zegerman P., Canas B., Pappin D., and Kouzarides T. Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex. J. Biol. Chem. 277 (2002) 11621-11624
106. Wysocka J., Swigut T., Milne T.A., Dou Y., Zhang X., Burlingame A.L., Roeder R.G., Brivanlou A.H., and Allis C.D. WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development. Cell 121 (2005) 859-872
107. Shyu Y.C., Lee T.L., Ting C.Y., Wen S.C., Hsieh L.J., Li Y.C., Hwang J.L., Lin C.C., and Shen C.K. Sumoylation of p45/NF-E2: Nuclear positioning and transcriptional activation of the mammalian beta-like globin locus. Mol. Cell. Biol. 25 (2005) 10365-10378
108. Hung H.L., Kim A.Y., Hong W., Rakowski C., and Blobel G.A. Stimulation of NF-E2 DNA binding by CREB-binding protein (CBP)-mediated acetylation. J. Biol. Chem. 276 (2001) 10715-10721
109. Versaw W.K., Blank V., Andrews N.M., and Bresnick E.H. Mitogen-activated protein kinases enhance long-range activation by the beta-globin locus control region. Proc. Natl. Acad. Sci. USA 95 (1998) 8756-8760
110. Forsberg E.C., Zaboikina T.N., Versaw W.K., Ahn N.G., and Bresnick E.H. Enhancement of beta-globin locus control region-mediated transactivation by mitogen-activated protein kinases through stochastic and graded mechanisms. Mol. Cell. Biol. 19 (1999) 5565-5575
111. Shivdasani R.A., Rosenblatt M.F., Zucker-Franklin D., Jackson C.W., Hunt P., Saris C.J., and Orkin S.H. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81 (1995) 695-704
112. Shivdasani R.A., and Orkin S.H. Erythropoiesis and globin gene expression in mice lacking the transcription factor NF-E2. Proc. Natl. Acad. Sci. USA 92 (1995) 8690-8694
113. Schulze H., and Shivdasani R.A. Mechanisms of thrombopoiesis. J. Thromb. Haemost. 3 (2005) 1717-1724
114. Forsberg E.C., Downs K.M., Christensen H.M., Im H., Nuzzi P.A., and Bresnick E.H. Developmentally dynamic histone acetylation pattern of a tissue-specific chromatin domain. Proc. Natl. Acad. Sci. USA 97 (2000) 14494-14499
115. Chan J.Y., Han X.L., and Kan Y.-W. Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc. Natl. Acad. Sci. USA 90 (1993) 11371-11375
116. Chan K., Lu R., Chang J.C., and Kan Y.W. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc. Natl. Acad. Sci. USA 93 (1996) 13943-13948
117. Oyake T., Itoh K., and Motohashi H. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol. Cell. Biol. 16 (1996) 6083-6095
118. Igarashi K., Hoshino H., Muto A., Suwabe N., Nishikawa S., Nakauchi H., and Yamamoto M. Multivalent DNA binding complex generated by small Maf and Bach1 as a possible biochemical basis for beta-globin locus control region complex. J. Biol. Chem. 273 (1998) 11783-11790
119. Martin F., van Deursen J.M., Shivdasani R.A., Jackson C.W., Troutman A.G., and Ney P.A. Erythroid maturation and globin gene expression in mice with combined deficiency of NF-E2 and Nrf-2. Blood 91 (1998) 3459-3466
120. Orkin S.H. GATA-binding transcription factors in hematopoietic cells. Blood 80 (1992) 575-581
121. Bresnick E.H., Martowicz M.L., Pal S., and Johnson K.D. Developmental control via GATA factor interplay at chromatin domains. J. Cell. Physiol. 205 (2005) 1-9
122. Reitman M., and Felsenfeld G. Mutational analysis of the chicken beta-globin enhancer reveals two positive-acting domains. Proc. Natl. Acad. Sci. USA 85 (1988) 6267-6271
123. Evans T., Reitman M., and Felsenfeld G. An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc. Natl. Acad. Sci. USA 85 (1988) 5976-5980
124. Merika M., and Orkin S.H. DNA-binding specificity of GATA family transcription factors. Mol. Cell. Biol. 13 (1993) 3999-4010
125. Ko L.J., and Engel J.D. DNA-binding specificities of the GATA transcription factor family. Mol. Cell. Biol. 13 (1993) 4011-4022
126. Martin D.I., and Orkin S.H. Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1. Genes Dev. 4 (1990) 1886-1898
127. Trainor C.D., Omichinski J.G., Vandergon T.L., Gronenborn A.M., Clore G.M., and Felsenfeld G. A palindromic regulatory site within vertebrate GATA-1 promoters requires both zinc fingers of the GATA-1 DNA-binding domain for high-affinity interaction. Mol. Cell. Biol. 16 (1996) 2238-2247
128. Newton A., MacKay J.P., and Crossley M. The N-terminal zinc finger of the erythroid transcription factor GATA-1 binds GATC motifs in DNA. J. Biol. Chem. 276 (2001) 35794-35801
129. Tsang A.P., Visvader J.E., Turner C.A., Fujuwara Y., Yu C., Weiss M.J., Crossley M., and Orkin S.H. FOG, a multitype zinc finger protein as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90 (1997) 109-119
130. Crispino J.D., Lodish M.B., MacKay J.P., and Orkin S.H. Use of altered specificity mutants to probe a specific protein-protein interaction in differentiation: The GATA-1: FOG complex. Mol. Cell 3 (1999) 219-228
131. Pal S., Cantor A.B., Johnson K.D., Moran T., Boyer M.E., Orkin S.H., and Bresnick E.H. Coregulator-dependent facilitation of chromatin occupancy by GATA-1. Proc. Natl. Acad. Sci. USA 101 (2004) 980-985
132. Letting D.L., Chen Y.Y., Rakowski C., Reedy S., and Blobel G.A. Context-dependent regulation of GATA-1 by friend of GATA-1. Proc. Natl. Acad. Sci. USA 101 (2004) 476-481
133. Grass J.A., Boyer M.E., Paul S., Wu J., Weiss M.J., and Bresnick E.H. GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc. Natl. Acad. Sci. USA 100 (2003) 8811-8816
134. Pevny L., Simon M.C., Robertson E., Klein W.H., Tsai S.F., D'Agati V., Orkin S.H., and Costantini F. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349 (1991) 257-260
135. Fujiwara Y., Browne C.P., Cunniff K., Goff S.C., and Orkin S.H. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl. Acad. Sci. USA 93 (1996) 12355-12358
136. Weiss M.J., Yu C., and Orkin S.H. Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line. Mol. Cell. Biol. 17 (1997) 1642-1651
137. Gregory T., Yu C., Ma A., Orkin S.H., Blobel G.A., and Weiss M.J. GATA-1 and erythropoietin cooperate to promoter erythroid cell survival by regulating bcl-xl expression. Blood 94 (1999) 87-96
138. Welch J.J., Watts J.A., Vakoc C.R., Yao Y., Wang H., Hardison R.C., Blobel G.A., Chodosh L.A., and Weiss M.J. Global regulation of erythroid gene expression by transcription factor GATA-1. Blood 104 (2004) 3136-3147
139. Martowicz M.L., Grass J.A., Boyer M.E., Guend H., and Bresnick E.H. Dynamic GATA factor interplay at a multi-component regulatory region of the GATA-2 locus. J. Biol. Chem. 280 (2005) 1724-1732
140. Pal S., Nemeth M.J., Bodine D.M., Miller J.L., Svaren J., Thein S.L., Lowry P.J., and Bresnick E.H. Neurokinin-B transcription in erythroid cells: Direct activation by the hematopoietic transcription factor GATA-1. J. Biol. Chem. 279 (2004) 31348-31356
141. Miller I.J., and Bieker J.J. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol. Cell. Biol. 13 (1993) 2776-2786
142. Bieker J.J. Kruppel-like factors: Three fingers in many pies. J. Biol. Chem. 276 (2001) 34355-34358
143. Basu P., Sargent T.G., Redmond L.C., Aisenberg J.C., Kransdorf E.P., Wang S.Z., Ginder G.D., and Lloyd J.A. Evolutionary conservation of KLF transcription factors and functional conservation of human gamma-globin gene regulation in chicken. Genomics 84 (2004) 311-319
144. Orkin S.H., Kazazian H.H., Antonarakis S.E., Goff S.C., Boehm C.D., Sexton J.P., Waber P.G., and Giardina P.J. Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Nature 296 (1982) 627-631
145. Orkin S.H., Antonarakis S.E., and Kazazian H.H. Base substitution at position -88 in a beta-thalassemic globin gene. Further evidence for the role of distal promoter element ACACCC. J. Biol. Chem. 867 (1984) 9-8681
146. Myers R.M., Tilly K., and Maniatis T. Fine structure genetic analysis of a beta-globin promoter. Science 232 (1986) 613-618
147. Perkins A.C., Sharpe A.H., and Orkin S.H. Lethal beta-thalassaemia in mice lacking the erythroid CACCC- transcription factor EKLF. Nature 375 (1995) 318-322
148. Nuez B., Michalovich D., Bygrave A., Ploemacher R., and Grosveld F. Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 375 (1995) 316-318
149. Milot E., Strouboulis J., Trimborn T., Wijgerde M., de Boer E., Langeveld A., Tan-Un K., Vergeer W., Yannoutsos N., Grosveld F., and Fraser P. Heterochromatin effects on the frequency and duration of LCR-mediated gene transcription. Cell 87 (1996) 105-114
150. Drissen R., von Lindern M., Kolbus A., Driegen S., Steinlein P., Beug H., Grosveld F., and Philipsen S. The erythroid phenotype of EKLF-null mice: Defects in hemoglobin metabolism and membrane stability. Mol. Cell. Biol. 25 (2005) 5205-5214
151. Hodge D., Coghill E., Keys J., Maguire T., Hartmann B., McDowall A., Weiss M., Grimmond S., and Perkins A. A global role for EKLF in definitive and primitive erythropoiesis. Blood 107 8 (2006) 3359-3370
152. Donze D., Townes T.M., and Bieker J.J. Role of erythroid Kruppel-like factor in human gamma- to beta-globin gene switching. J. Biol. Chem. 270 (1995) 1955-1959
153. Perkins A.C., Gaensler K.M., and Orkin S.H. Silencing of human fetal globin expression is impaired in the absence of the adult beta-globin gene activator protein EKLF. Proc. Natl. Acad. Sci. USA 93 (1996) 12267-12271
154. Wijgerde M., Gribnau J., Trimborn T., Nuez B., Philipsen S., Grosveld F., and Fraser P. The role of EKLF in human beta-globin gene competition. Genes Dev. 10 (1996) 2894-2902
155. Asano H., and Stamatoyannopoulos G. Activation of beta-globin promoter by erythroid Kruppel-like factor. Mol. Cell. Biol. 18 (1998) 102-109
156. Gillemans N., Tewari R., Lindeboom F., Rottier R., de Wit T., Wijgerde M., Grosveld F., and Philipsen S. Altered DNA-binding specificity mutants of EKLF and Sp1 show that EKLF is an activator of the beta-globin locus control region in vivo. Genes Dev. 12 (1998) 2863-2873
157. Gregory R.C., Taxman D.J., Seshasayee D., Kensinger M.H., Bieker J.J., and Wojchowski D.M. Functional interaction of GATA1 with erythroid Kruppel-like factor and Sp1 at defined erythroid promoters. Blood 87 (1996) 1793-1801
158. Merika M., and Orkin S.H. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Kruppel family proteins Sp1 and EKLF. Mol. Cell. Biol. 15 (1995) 2437-2447
159. Zhang W., Kadam S., Emerson B.M., and Bieker J.J. Site-specific acetylation by p300 or CREB binding protein regulates erythroid Kruppel-like factor transcriptional activity via its interaction with the SWI-SNF complex. Mol. Cell. Biol. 21 (2001) 2413-2422
160. Armstrong J.A., Bieker J.J., and Emerson B.M. A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro. Cell 95 (1998) 93-104
161. Brown R.C., Pattison S., van Ree J., Coghill E., Perkins A., Jane S.M., and Cunningham J.M. Distinct domains of erythroid Kruppel-like factor modulate chromatin remodeling and transactivation at the endogenous beta-globin gene promoter. Mol. Cell. Biol. 22 (2002) 161-170
162. Tewari R., Gillemans N., Wijgerde M., Nuez B., von Lindern M., Grosveld F., and Philipsen S. Erythroid Kruppel-like factor (EKLF) is active in primitive and definitive erythroid cells and is required for the function of 5′HS3 of the beta-globin locus control region. EMBO J. 17 (1998) 2334-2341
163. Imbalzano A.N., and Xiao H. Functional properties of ATP-dependent chromatin remodeling enzymes. Adv. Protein Chem. 67 (2004) 157-179
164. Wang W. The SWI/SNF family of ATP-dependent chromatin remodelers: Similar mechanisms for diverse functions. Curr. Top. Microbiol. Immunol. 274 (2003) 143-169
165. Kadam S., McAlpine G.S., Phelan M.L., Kingston R.E., Jone K.A., and Emerson B.M. Functional selectivity of recombinant mammalian SWI/SNF subunits. Genes Dev. 14 (2000) 2441-2451
166. Bultman S.J., Gebuhr T.C., and Magnuson T. A Brg 1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI/SNF complexes in beta-globin expression and erythroid development. Genes Dev. 19 (2005) 2849-2861
167. O'Neill D., Yang J., Erdjument-Bromage H., Bornschlegel K., Tempst P., and Bank A. Tissue-specific and developmental stage-specific DNA binding by a mammalian SWI/SNF complex associated with human fetal-to-adult globin gene switching. Proc. Natl. Acad. Sci. USA 96 (1999) 349-354
168. O'Neill D.W., Schoetz S.S., Lopez R.A., Castle M., Rabinowitz L., Shor E., Krawchuk D., Goll M.G., Renz M., Seelig H.P., Han S., Seong R.H., et al. An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells. Mol. Cell. Biol. 20 (2000) 7572-7582
169. Georgopoulos K., Bigby M., Wang J.H., Molnar A., Wu P., Winandy S., and Sharpe A. The lkaros gene is required for the development of all lymphoid lineages. Cell 79 (1994) 143-156
170. Lopez R.A., Schoetz S., DeAngelis K., O'Neill D., and Bank A. Multiple hematopoietic defects and delayed globin switching in lkaros null mice. Proc. Natl. Acad. Sci. USA 99 (2002) 602-607
171. Mahajan M.C., Narkikar G.J., Boyapaty G., Kingston R.E., and Weissman S.M. Heterogeneous nuclear ribonucleoprotein C1/C2. MeCP1, and SWI/SNF form a chromatin remodeling complex at the beta-globin locus control region. Proc. Natl. Acad. Sci. USA 102 (2005) 15012-15017
172. Im H., Grass J.A., Johnson K.D., Boyer M.E., Wu J., and Bresnick E.H. Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation. Methods Mol. Biol. 284 (2004) 129-146
173. Weinmann A.S., Yan P.S., Oberley M.J., Huang T.H., and Farnham P.J. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev. 16 (2002) 235-244
174. Ren B., Robert F., Wyrick J.J., Aparicio O., Jennings E.G., Simon I., Zeitlinger J., Schreiber J., Hannett N., Kanin E., Volkert T.L., Wilson C.J., et al. Genome-wide location and function of DNA binding proteins. Science 290 (2000) 2306-2309
175. Forsberg E.C., and Bresnick E.H. Histone acetylation beyond promoters: Long-range acetylation patterns in the chromatin world. Bioessays 23 (2001) 820-830
176. Im H., Park C., Feng Q., Johnson K.D., Kiekhaefer C.M., Choi K., Zhang Y., and Bresnick E.H. Dynamic regulation of histone H3 methylated at lysine 79 within a tissue-specific chromatin domain. J. Biol. Chem. 278 (2003) 18346-18352
177. Kim A., and Dean A. Developmental stage differences in chromatin subdomains of the beta-globin locus. Proc. Natl. Acad. Sci. USA 101 (2004) 7028-7033
178. Perrine S.P., Rudolph A., Faller D.V., Roman C., Cohen R.A., Chen S.J., and Kan Y.W. Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching. Proc. Natl. Acad. Sci. USA 85 (1988) 8540-8552
179. Liakopoulou E., Blau C.A., Li Q., Josephson B., Wolf J.A., Fournarakis B., Raisys V., Dover G., Papayannopoulou T., and Stamatoyannopoulos G. Stimulation of fetal hemoglobin production by short chain fatty acids. Blood 86 (1995) 3227-3235
180. McCaffrey P.G., Newsome D.A., Fibach E., Yoshida M., and Su M.S. Induction of gamma-globin by histone deacetylase inhibitors. Blood 90 (1997) 2075-2083
181. Cao H., Satamatoyannopoulos G., and Jung M. Induction of human gamma globin gene expression by histone deacetylase inhibitors. Blood 103 (2004) 701-709
182. Atweh G.F., Sutton M., Nassif I., Boosalis V., Dover G.J., Wallenstein S., Wright E., McMahon L., Stamatoyannopoulos G., Faller D.V., and Perrine S.P. Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood 93 (1999) 1790-1797
183. Im H., Grass J.A., Christensen H.M., Perkins A., and Bresnick E.H. Histone deacetylase-dependent establishment and maintenance of broad low-level histone acetylation within a tissue-specific chromatin domain. Biochem. 41 (2002) 15152-15160
184. Ley T.J., DeSimone J., Noguchi C.T., Turner P.H., Schechter A.N., Heller P., and Nienhuis A.W. 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia. Blood 62 (1983) 370-380
185. Letting D.L., Rakowski C., Weiss M.J., and Blobel G.A. Formation of a tissue-specific histone acetylation pattern by the hematopoietic transcription factor GATA-1. Mol. Cell. Biol. 23 (2003) 1334-1340
186. van Leeuwen F., Gafken P.R., and Gottschling D.E. Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell 109 (2002) 745-756
187. Blobel G.A., Nakajima T., Eckner R., Montminy M., and Orkin S.H. CREB-binding protein cooperates with transcription factor GATA-1 and is required for erythroid differentiation. Proc. Natl. Acad. Sci. USA 95 (1998) 2061-2066
188. Forsberg E.C., Johnson K., Zaboikina T.N., Mosser E.A., and Bresnick E.H. Requirement of an E1A-sensitive coactivator for long-range transactivation by the beta-globin locus control region. J. Biol. Chem. 274 (1999) 26850-26859
189. Hung H.L., Lau J., Kim A.Y., Weiss M.J., and Blobel G.A. CREB-binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites. Mol. Cell. Biol. 19 (1999) 3496-3505
190. Yang X.J., Ogryzko V.V., Nishikawa J., Howard B.H., and Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382 (1996) 319-324
191. Ogryzko V.V., Kotani T., Zhang X., Schlitz R.L., Howard T., Yang X.J., Howard B.H., Qin J., and Nakatani Y. Histone-like TAFs within the PCAF histone acetylase complex. Cell 94 (1998) 35-44
192. Yagi R., Chen L.F., Shigesada K., Murakami Y., and Ito Y. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional coactivator. EMBO J. 18 (1999) 2551-2562
193. Komuro A., Nagai M., Navin N.E., and Sudol M. WW domain-containing protein YAP associates with ErbB-4 and acts as a cotranscriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J. Biol. Chem. 278 (2003) 33334-33341
194. Kanai F., Marignani P.A., Sarbassova D., Yagi R., Hall R.A., Donowiwtz M., Hisaminato A., Fujiwara T., Ito Y., Cantley L.C., and Yaffe M.B. TAZ: A novel transcriptional coactivator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 19 (2000) 6778-6791
195. Staub O., Dho S., Henry P., Correa J., Ishikawa T., McGlade J., and Rotin D. WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle's syndrome. EMBO J. 15 (1996) 2371-2380
196. Huang K., Johnson K.D., Petcherski A.G., Vandergon T., Mosser E.A., Copeland N.G., Jenkins N.A., Kimble J., and Bresnick E.H. A HECT domain ubiquitin ligase closely related to the mammalian protein WWP1 is essential for Caenorhabditis elegans embryogenesis. Gene 252 (2000) 137-145
197. Chen X., Wen S., Fukuda M.N., Gavva N.R., Hsu D., Akamo T.O., Yang-Feng T., and Shen C.K. Human Itch is a coregulator of the hematopoietic transcription factor NF-E2. Genomics 73 (2001) 238-241
198. Nawaz Z., Lonard D.M., Smith C.L., Lev-Lehman E., Tsai S.Y., Tsai M.J., and O'Malley B.W. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19 (1999) 1182-1189
199. Bender M.A., Bulger M., Close J., and Groudine M. Beta-globin gene switching and DNasel sensitivity of the endogenous beta-globin locus in mice do not require the locus control region. Mol. Cell 5 (2000) 387-393
200. Epner E., Reik A., Cimbora D., Telling A., Bender M.A., Fiering S., Enver T., Martin D.I., Kennedy M., Keller G., and Groudine M. The beta-globin LCR is not necessary for an open chromatin structure or developmentally regulated transcription of the native mouse beta-globin locus. Mol. Cell 2 (1998) 447-455
201. Schubeler D., Francastel C., Cimbora D.M., Reik A., Martin D.I., and Groudine M. Nuclear localization and histone acetylation: A pathway for chromatin opening and transcriptional activation of the human beta-globin locus. Genes Dev. 14 (2000) 940-950
202. Schubeler D., Groudine M., and Bender M.A. The murine beta-globin locus control region regulates the rate of transcription but not the hyperacetylation of histones at the active genes. Proc. Natl. Acad. Sci. USA 98 (2001) 11432-11437
203. Sawado T., Halow J., Bender M.A., and Groudine M. The beta-globin locus control region (LCR) functions primarily by enhancing the transition from transcription initiation to elongation. Genes Dev. 17 (2003) 1009-1118
204. Fischle W., Wang Y., and Allis C.D. Histone and chromatin crosstalk. Curr. Opin. Cell Biol. 15 (2003) 172-183
205. Sproul D., Gilbert N., and Bickmore W.A. The role of chromatin structure in regulating the expression of clustered genes. Nat. Rev. Genet. 6 (2005) 775-781
206. Allfrey V., Faulkner R.M., and Mirsky A.E. Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc. Natl. Acad. Sci. USA 51 (1964) 786-794
207. Hebbes T.R., Clayton A.L., Thorne A.W., and Crane-Robinson C. Core histone hyperacetylation co-maps with generalized DNase I sensitivity in the chicken beta-globin chromosomal domain. EMBO J. 13 (1994) 1823-1830
208. Wu J., Iwata F., Grass J.A., Osborne C.S., Elnitski L., Fraser P., Ohneda O., Yamamoto M., and Bresnick E.H. Molecular determinants of NOTCH4 transcription in vascular endothelium. Mol. Cell. Biol. 25 (2005) 1458-1474
209. Conkright M.D., Guzman E., Flechner L., Su A.I., Hogenesch J.B., and Montminy M. Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. Mol. Cell 11 (2003) 1101-1108
210. Udalova I.A., Mott R., Field D., and Kwiatkowski D. Quantitative prediction of NF-kappa B DNA-protein interaction. Proc. Natl. Acad. Sci. USA 99 (2002) 8167-8172
211. Minokawa T., Wikramanayake A.H., and Davidson E.H. Cis-regulatory inputs of the wnt8 gene in the sea urchin endomesoderm network. Dev. Biol. 288 (2005) 545-558